Results 81 to 90 of about 12,754 (124)

Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma. [PDF]

Medicine (Baltimore), 2021
Liao C, Wang A, Ma Y, Liu H.
europepmc   +1 more source

Histomorphological Spectrum of Ovarian Tumors with Immunohistochemical Analysis of Poorly or Undifferentiated Malignancies

Gomal Journal of Medical Sciences, 2012
Background: Ovarian cancer has the worst prognosis and highest case fatality rate among all gynecological malignancies. Differential diagnosis remains a major problem in histopathology of ovarian tumors especially for poorly differentiated or ...
Farheen Danish, Mohammed Saleem Khanzada, Talat Mirza, Saadiya Aziz, Erum Naz, Mohammed Nadeem Khan   +5 more
doaj  

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma. [PDF]

Clin Transl Med, 2021
Shi Z, Zhao Q, Lv B, Qu X, Han X, Wang H, Qiu J, Hua K.   +7 more
europepmc   +1 more source

Distribution of Ovarian Tumors in Zonguldak Karaelmas University Hospital. Between 2001 and 2007

Gynecology Obstetrics & Reproductive Medicine, 2008
OBJECTIVE: There are numerous types of ovarian tumors, both benign and malignant. The aim of this study was to evaluate the epidemiology of ovarian tumors in Zonguldak and surrounding cities, retrospectively. STUDY DESIGN: Between May 2001 and March 2007,
Figen Barut, Aykut Barut, Gürkan Kertiş, Sibel Bektaş, Banu Doğan Gün, Burak Bahadır, Gamze Yurdakan, Şükrü Oğuz Özdamar   +7 more
doaj  

Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis. [PDF]

Biomed Res Int, 2020
Liu H, Wang A, Ma Y.
europepmc   +1 more source

Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after based on SEER database. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban, 2021
Chen X, Guo T.
europepmc   +1 more source

Bilateral ovarian serous cystadenocarcinoma with peritoneal dissemination and a coexisting cervical mass: A diagnostic dilemma. [PDF]

Radiol Case Rep
Hussein A, Alshoabi SA, Gareeballah A, Alsaiany A, Almutamaiz AH, Elkady RM, Alsaedi A, Alamin A.   +7 more
europepmc   +1 more source

NETosis Genes and Pathomic Signature: A Novel Prognostic Marker for Ovarian Serous Cystadenocarcinoma. [PDF]

J Imaging Inform Med
Zhan F, Guo Y, He L.
europepmc   +1 more source

High Expression of TBC1 Domain Family Member 22A is Related to Poor Prognosis in Ovarian Serous Cystadenocarcinoma. [PDF]

Int J Med Sci
Lv X, Gong R, Guo L, Wang C.
europepmc   +1 more source

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma. [PDF]

Front Genet, 2020
He Y, Zeng S, Hu S, Zhang F, Shan N.
europepmc   +1 more source